Anemia with renal tubular damage is an independent predictor of mortality in the general population. Anemia along with renal tubular damage (RTD) is associated with all-cause mortality in the general ...

A 45-year-old woman with stage 5 chronic kidney disease (CKD) due to lupus nephritis visits the nephrology clinic for routine follow-up. She has no overt uremic symptoms. There is no shortness of ...

Anemia is a common issue in patients with chronic kidney disease (CKD), with up to 60% of those not on dialysis reported to have anemia. 1 The usual approach to managing anemia in CKD is with oral or ...

The US Food and Drug Administration (FDA) has approved daprodustat (Jesduvroq), the first oral treatment for anemia caused by chronic kidney disease (CKD) in adults who have been on dialysis for at ...

The Food and Drug Administration has approved Jesduvroq tablets (daprodustat), the first oral treatment for renal disease-related anemia in adults who have been on dialysis for four months or more, ...

November 14, 2008 — Preventing anemia may improve quality of life (QofL) in patients with kidney disease, according to the results of a cross-sectional study published online November 5, 2008, in the ...

Please provide your email address to receive an email when new articles are posted on . During the last 3 decades, only one class of drugs – erythropoiesis-stimulating agents – has been available to ...

NEW YORK (Reuters Health) - Treatment with ferumoxytol, a new iron drug that is given intravenously, is more effective against anemia than standard iron therapy, which is given by mouth, in patients ...

Chronic kidney disease affects 1 in 7 U.S. adults, underscoring the importance of early detection and management. This ...